Press Resease

Opioid Use Disorder Market by Drug (Buprenorphine, Methadone and Naltrexone) – Global Industry Perspective Comprehensive Analysis and Forecast, 2019-2025

Published Date: 27-Nov-2019 Category: Healthcare Report Format : PDF Pages: 130 Report Code: ZMR-5103 Status : Published

Global demand for Opioid Use Disorder Market was valued at approximately USD 1500.39 Million in 2018, and is expected to generate revenue of around USD 2853.57 Million by end of 2025, growing at a CAGR of around 9.69% between 2018 and 2025.

Description

The report covers forecast and analysis for the Opioid Use Disorder market on a global and regional level. The study provides historic data from 2016 to 2018 along with a forecast from 2019 to 2025 based on revenue (USD Million). The study includes drivers and restraints for the Opioid Use Disorder market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the Opioid Use Disorder market on a global level. In order to give the users of this report a comprehensive view on the Opioid Use Disorder market we have included competitive landscape and analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein Drug and regional segments are benchmarked based on their market size, growth rate and general attractiveness.

According to the report, global demand for Opioid Use Disorder Market was valued at approximately USD 1500.39 Million in 2018, and is expected to generate revenue of around USD 2853.57 Million by end of 2025, growing at a CAGR of around 9.69% between 2018 and 2025.

Opioids, used for pain relief medicinally, have depressing effects on the analgesic and central nervous system as well as the potential for euphoria. Opioid use disorder (OUD) may include misuse of prescribed opioid drugs, use of diverted opioid drugs, or use of unlawfully obtained heroin. Opioid use disorder is typically a chronic, recurrent disease associated with significantly higher morbidity and mortality rates.

The study provides a decisive view on the Opioid Use Disorder market by segmenting the market based on Product, End user and regions. All the segments have been analyzed based on present and future trends and the market is estimated from 2019 to 2025. Based on Drugs, the market is segmented into Buprenorphine, Methadone and Naltrexone. Buprenorphine is further classified into Bunavail, Sublocade, Suboxone, Zubsolv and Others. The largest revenue generating segment in 2018 was buprenorphine. The most widely prescribed drugs for opioid use disorder include buprenorphine / naloxone sublingual tablet, branded suboxone and buprenorphine sublingual tablet. Because of its excellent clinical profile, Suboxone Film is the most prescribed drug on the opioid use disorder market. High effectiveness in addiction treatment, low potential for abuse & relatively slight adverse effects and favorable type exposure are factors that can be contributed to this drug's high acceptance.

The geographical segmentation comprises the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America was the biggest revenue-generating market in 2018 and over the forecast period is expected to show the same pattern. The U.S. and Canada's opioid epidemic is one of the major contributing factors to North America's largest market share. Governments are implementing a number of policies to manage the crisis.

The growing number of patients suffering from opiod-related addiction, rising government initiatives and increasing support from NGOs and agensis are key factors driving the market for disorder treatment for opioid use. With the help of government agencies and many others, the NGOs coordinate various programs and campaigns to increase awareness of the clinical ill-effects of Opioid abuse. These programs are aimed at eradicating illicit drug use in federal workplaces and contributing to drug-free all workplaces. However, individuals ' reluctance to access treatment modalities and the discontinuation of behavioral therapies that lead to relapse are the factors that restrict this market's growth. Crucial opportunities for this market are government initiatives and funding.

Key players within global Opioid Use Disorder market include Indivior, Alkermes, Titan Pharmaceuticals, Hikma Pharmaceuticals, Teva Pharmaceuticals, MediciNova, Orexo, Camurus, and Omeros amongst others.

The report segments global Opioid Use Disorder market as follows:

Global Opioid Use Disorder Market: Drug Segment Analysis

  • Buprenorphine
    • Bunavail
    • Sublocade
    • Suboxone
    • Zubsolv
    • Others
  • Methadone
  • Naltrexone

Global Opioid Use Disorder Market: Regional Segment Analysis

  • North America
    • U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • Middle East and Africa

Table Of Content

  • Chapter 1. Preface
    • 1.1. Report Description and Scope
    • 1.2. Research Scope
    • 1.3. Research Methodology
      • 1.3.1. Market Research Process
      • 1.3.2. Market Research Methodology
  • Chapter 2. Executive Summary
    • 2.1. Opioid Use Disorder Market, 2016 - 2025, (USD Million)
    • 2.2. Opioid Use Disorder Market: Snapshot
  • Chapter 3. Global Opioid Use Disorder Market - Industry Analysis
    • 3.1. Opioid Use Disorder Market: Market Dynamics
    • 3.2. Market Drivers
      • 3.2.1. Rising opioid use
    • 3.3. Restraints
      • 3.3.1. Regulatory stringency
    • 3.4. Opportunity
      • 3.4.1. Government funding and support
    • 3.5. Porter's Five Forces Analysis
    • 3.6. Market Attractiveness Analysis
      • 3.6.1. Market attractiveness analysis by Drug Segment
      • 3.6.2. Market attractiveness analysis by regional segment
  • Chapter 4. Global Opioid Use Disorder Market - Competitive Landscape
    • 4.1. Company market share analysis
      • 4.1.1. Global Opioid Use Disorder market: company market share analysis, 2018
    • 4.2. Strategic development
      • 4.2.1. Acquisitions & mergers
      • 4.2.2. New product launches
      • 4.2.3. Agreements, partnerships, collaborations and joint ventures
      • 4.2.4. Research and development and regional expansion
  • Chapter 5. Global Opioid Use Disorder Market - Product Segment Analysis
    • 5.1. Global Opioid Use Disorder market overview: by Product
      • 5.1.1. Global Opioid Use Disorder market revenue share, by Product, 2018 and 2025
    • 5.2. Buprenorphine
      • 5.2.1. Global Opioid Use Disorder market by Buprenorphine, 2016-2025 (USD Million)
      • 5.2.2. Bunavail
        • 5.2.2.1. Global Opioid Use Disorder market by Bunavail, 2016-2025 (USD Million)
      • 5.2.3. Sublocade
        • 5.2.3.1. Global Opioid Use Disorder market by Sublocade, 2016-2025 (USD Million)
      • 5.2.4. Suboxone
        • 5.2.4.1. Global Opioid Use Disorder market by Suboxone, 2016-2025 (USD Million)
      • 5.2.5. Zubsolv
        • 5.2.5.1. Global Opioid Use Disorder market by Zubsolv, 2016-2025 (USD Million)
      • 5.2.6. Others
        • 5.2.6.1. Global Opioid Use Disorder market by Others, 2016-2025 (USD Million)
    • 5.3. Methadone
      • 5.3.1. Global Opioid Use Disorder market by Sleep monitoring devices, 2016-2025 (USD Million)
    • 5.4. Naltrexone
      • 5.4.1. Global Opioid Use Disorder market by Sleep monitoring devices, 2016-2025 (USD Million)
  • Chapter 6. Global Opioid Use Disorder Market - Regional Analysis
    • 6.1. Global Opioid Use Disorder market overview: by region
      • 6.1.1. Global Opioid Use Disorder market revenue share, by region, 2018 and 2025
    • 6.2. North America
      • 6.2.1. North America Opioid Use Disorder market, by country, 2016-2025 (USD Million)
      • 6.2.2. North America Opioid Use Disorder market revenue, by Drug, 2016-2025 (USD Million)
      • 6.2.3. The U.S.
        • 6.2.3.1. The U.S. Opioid Use Disorder market revenue, by Drug, 2016-2025 (USD Million)
      • 6.2.4. Rest of North America
        • 6.2.4.1. Rest of North America Opioid Use Disorder market revenue, by Drug, 2016-2025 (USD Million)
    • 6.3. Europe
      • 6.3.1. Europe Opioid Use Disorder market, by country, 2016-2025 (USD Million)
      • 6.3.2. Europe Opioid Use Disorder market revenue, by Drug, 2016-2025 (USD Million)
      • 6.3.3. U.K.
        • 6.3.3.1. U.K. Opioid Use Disorder market revenue, by Drug, 2016-2025 (USD Million)
      • 6.3.4. France
        • 6.3.4.1. France Opioid Use Disorder market revenue, by Drug, 2016-2025 (USD Million)
      • 6.3.5. Germany
        • 6.3.5.1. Germany Opioid Use Disorder market revenue, by Drug, 2016-2025 (USD Million)
      • 6.3.6. Rest of Europe
        • 6.3.6.1. Rest of Europe Opioid Use Disorder market revenue, by Drug, 2016-2025 (USD Million)
    • 6.4. Asia Pacific
      • 6.4.1. Asia Pacific Opioid Use Disorder market, by country, 2016-2025 (USD Million)
      • 6.4.2. Asia Pacific Opioid Use Disorder market revenue, by Drug, 2016-2025 (USD Million)
      • 6.4.3. China
        • 6.4.3.1. China Opioid Use Disorder market revenue, by Drug, 2016-2025 (USD Million)
      • 6.4.4. Japan
        • 6.4.4.1. Japan Opioid Use Disorder market revenue, by Drug, 2016-2025 (USD Million)
      • 6.4.5. India
        • 6.4.5.1. India Opioid Use Disorder market revenue, by Drug, 2016-2025 (USD Million)
      • 6.4.6. Rest of Asia Pacific
        • 6.4.6.1. Rest of Asia Pacific Opioid Use Disorder market revenue, by Drug, 2016-2025 (USD Million)
    • 6.5. Latin America
      • 6.5.1. Latin America Opioid Use Disorder market, by country, 2016-2025 (USD Million)
      • 6.5.2. Latin America Opioid Use Disorder market revenue, by Drug, 2016-2025 (USD Million)
      • 6.5.3. Brazil
        • 6.5.3.1. Brazil Opioid Use Disorder market revenue, by Drug, 2016-2025 (USD Million)
      • 6.5.4. Rest of Latin America
        • 6.5.4.1. Rest of Latin America Opioid Use Disorder market revenue, by Drug, 2016-2025 (USD Million)
    • 6.6. Middle East & Africa
      • 6.6.1. Middle East & Africa Opioid Use Disorder market, 2016-2025 (USD Million)
      • 6.6.2. Middle East & Africa Opioid Use Disorder market revenue, by Drug, 2016-2025 (USD Million)
  • Chapter 7. Company Profiles
    • 7.1. Autonomic Technologies (ATI)
      • 7.1.1. Overview
      • 7.1.2. Financials
      • 7.1.3. Product Portfolio
      • 7.1.4. Business Strategy
      • 7.1.5. Recent Developments
    • 7.2. Baxter Healthcare Corporation
      • 7.2.1. Overview
      • 7.2.2. Financials
      • 7.2.3. Product Portfolio
      • 7.2.4. Business Strategy
      • 7.2.5. Recent Developments
    • 7.3. Bionano Genomics
      • 7.3.1. Overview
      • 7.3.2. Financials
      • 7.3.3. Product Portfolio
      • 7.3.4. Business Strategy
      • 7.3.5. Recent Developments
    • 7.4. Compumedics Limited
      • 7.4.1. Overview
      • 7.4.2. Financials
      • 7.4.3. Product Portfolio
      • 7.4.4. Business Strategy
      • 7.4.5. Recent Developments
    • 7.5. Infraredx, Inc.
      • 7.5.1. Overview
      • 7.5.2. Financials
      • 7.5.3. Product Portfolio
      • 7.5.4. Business Strategy
      • 7.5.5. Recent Developments
    • 7.6. Inovio, Pharmaceuticals
      • 7.6.1. Overview
      • 7.6.2. Financials
      • 7.6.3. Product Portfolio
      • 7.6.4. Business Strategy
      • 7.6.5. Recent Developments
    • 7.7. Masimo Corporation
      • 7.7.1. Overview
      • 7.7.2. Financials
      • 7.7.3. Product Portfolio
      • 7.7.4. Business Strategy
      • 7.7.5. Recent Developments
    • 7.8. Neovasc Inc.
      • 7.8.1. Overview
      • 7.8.2. Financials
      • 7.8.3. Product Portfolio
      • 7.8.4. Business Strategy
      • 7.8.5. Recent Developments
    • 7.9. Nihon Kohden Corporation, Inc.
      • 7.9.1. Overview
      • 7.9.2. Financials
      • 7.9.3. Product Portfolio
      • 7.9.4. Business Strategy
      • 7.9.5. Recent Developments

Methodology

Office Address

Corporate Office
Zion Market Research 244 Fifth Avenue, Suite N202 New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll Free No.1-855-465-4651

Asia Pacific Office
3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #
US OFFICE NO +1-386-310-3803
US/CAN TOLL FREE +1-855-465-4651
Email: sales@zionmarketresearch.com